Lakeview TMS Center

Teen depression impacts millions of families each year. For some adolescents, traditional antidepressant treatment may not provide adequate relief.​

NeuroStar® Advanced Therapy is an FDA-cleared, non-invasive adjunct treatment option for adolescents ages 15–21 with major depressive disorder. Clinical data show meaningful improvement and remission rates in teens treated with NeuroStar.*​

If you are exploring options for a teen in your life, schedule a consultation to learn more.



*FDA Clearance K231926 The outcomes reported represent the subset of study patients for which the CGI-S data was reported before and after an acute course of NeuroStar TMS. Patients aged 12 to 21 (average 19.2 ± 1.5) were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score ≤3 and “complete remission” was defined as a CGI-S
score ≤2 at the end of treatment.

Depression affects more than emotions.

It can impact energy, focus, sleep, and daily functioning. It may even affect relationships and work performance.

Recognizing these symptoms is an important step toward seeking help. If you’re thinking about taking the next step in exploring treatment for your depression, we’re here to help. Schedule a consultation to learn more.



https://stigmafree.nami.org/guides/what-you-need-to-know-about-mental-health-know-the-warning-signs-and-find-support/

NeuroStar is typically delivered in a series of 36 in-office sessions over several weeks. Each session is performed while you remain awake and alert, with no anesthesia required and no recovery time afterward.

Patients are able to return to normal daily activities immediately following treatment.

If you’re exploring new options, schedule a consultation to learn whether NeuroStar may be right for you.